Excision of Lymph Node Trial (EXCILYNT) (Mel69)

NARecruitingINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 6, 2023

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions
Melanoma
Interventions
PROCEDURE

Excision of clinically detected lymph node metastasis before any systemic therapy

Surgical intervention to remove the clinically detected lymph node metastasis after which physician choice adjuvant systemic therapy is permitted

PROCEDURE

Excision of clinically detected lymph node metastasis after neoadjuvant systemic therapy

Surgical intervention to remove the clinically detected lymph node metastasis after physician choice neo adjuvant systemic therapy. Physician choice adjuvant therapy is allowed after surgery

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

19104

NOT_YET_RECRUITING

University of Pennsylvania, Philadelphia

21201

NOT_YET_RECRUITING

University of Maryland, Baltimore

22908

RECRUITING

Cancer Center at the University of Virginia, Charlottesville

27710

RECRUITING

Duke University Health System, Durham

30322

RECRUITING

Emory University, Atlanta

48109

RECRUITING

University of Michigan, Ann Arbor

All Listed Sponsors
lead

Craig L Slingluff, Jr

OTHER